Noyes AA, Whitney WR. The rate of solution of solid substances in their own solutions. J Am Chem Soc. 1897;19:930–4.
Article
Google Scholar
Brunner E. Reaktionsgeschwindigkeit in heterogenen Systemen. Z Phys Chem. 1904;43:56–102.
Google Scholar
Nernst W. Theorie der Reaktionsgeschwindigkeit in heterogenen Systemen. Z Phys Chem. 1904;47:52–5.
CAS
Google Scholar
Macheras P, Dokoumetzidis A. On the heterogeneity of drug dissolution and release. Pharm Res. 2000;17(2):108–12.
CAS
Article
PubMed
Google Scholar
Weibull W. A statistical distribution function of wide applicability. J Appl Mech. 1951;18:293–7.
Google Scholar
Langenbucher F. Linearization of dissolution rate curves by the Weibull distribution. J Pharm Pharmacol. 1972;24:979–81.
CAS
Article
PubMed
Google Scholar
Costa P, Lobo JS. Influence of dissolution medium agitation on release profiles of sustained-release tablets. Drug Dev Ind Pharm. 2001;27(8):811–7.
CAS
Article
Google Scholar
Missaghi S, Fassihi R. Release characterization of dimenhydrinate from an eroding and swelling matrix: selection of appropriate dissolution apparatus. Int J Pharm. 2005;293(1):35–42.
CAS
Article
PubMed
Google Scholar
Pillay V, Fassihi R. Unconventional dissolution methodologies. J Pharm Sci. 1999;88(9):843–51.
CAS
Article
PubMed
Google Scholar
Underwood FL, Cadwallader DE. Effects of various hydrodynamic conditions on dissolution rate determinations. J Pharm Sci. 1976;65(5):697–700.
CAS
Article
PubMed
Google Scholar
Shah VP, Gurbarg M, Noory A, Dighe S, Skelly JP. Influence of higher rates of agitation on release patterns of immediate-release drug products. J Pharm Sci. 1992;81(6):500–3.
CAS
Article
PubMed
Google Scholar
Jamzad S, Fassihi R. Role of surfactant and pH on dissolution properties of fenofibrate and glipizide—a technical note. AAPS PharmScitech. 2006;7(2):E17–22.
Article
PubMed Central
Google Scholar
Pillay V, Fassihi R. A new method for dissolution studies of lipid-filled capsules employing nifedipine as a model drug. Pharm Res. 1999;16(2):333–7.
CAS
Article
PubMed
Google Scholar
Mirza T, Joshi Y, Liu Q, Vivilecchia R. Evaluation of dissolution hydrodynamics in the USP, Peak™ and flat-bottom vessels using different solubility drugs. Dissolution Technol. 2005;12(1):11–6.
CAS
Article
Google Scholar
Röst M, Quist PO. Dissolution of USP prednisone calibrator tablets: effects of stirring conditions and particle size distribution. J Pharm Biomed Anal. 2003;31(6):1129–43.
Article
PubMed
Google Scholar
Wurster DE, Taylor PW. Dissolution rates. J Pharm Sci. 1965;54(2):169–75.
CAS
Article
PubMed
Google Scholar
Levy G. Effect of particle size on dissolution and gastrointestinal absorption rates of pharmaceuticals. Am J Pharm Sci Support Public Health. 1963;135:78–92.
CAS
PubMed
Google Scholar
Shaw LR, Irwin WJ, Grattan TJ, Conway BR. The effect of selected water-soluble excipients on the dissolution of paracetamol and ibuprofen. Drug Dev Ind Pharm. 2005;31(6):515–25.
CAS
Article
PubMed
Google Scholar
Yuksel N, Kanık AE, Baykara T. Comparison of in vitro dissolution profiles by ANOVA-based, model-dependent and-independent methods. Int J Pharm. 2000;209(1):57–67.
CAS
Article
PubMed
Google Scholar
Peppas NA. Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv. 1985;60:110–1.
CAS
PubMed
Google Scholar
Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci. 1963;52:1145–9.
CAS
Article
PubMed
Google Scholar
Varelas CG, Dixon DG, Steiner C. Zero-order release from biphasic polymer hydrogels. J Control Release. 1995;34:185–92.
CAS
Article
Google Scholar
Mulye NV, Turco SJ. A simple model based on first order kinetics to explain release of highly water soluble drugs from porous dicalcium phosphate dihydrate matrices. Drug Dev Ind Pharm. 1995;21:943–53.
CAS
Article
Google Scholar
Baker RW, Lonsdale HS. Controlled release: mechanisms and rates. In: Taquary AC, Lacey RE, editors. Controlled release of biologically active agents. New York: Plenum Press; 1974. p. 15–71.
Chapter
Google Scholar
Hixson AW, Crowell JH. Dependence of reaction velocity upon surface and agitation. Ind Eng Chem. 1931;23:923–31.
CAS
Article
Google Scholar
Goldsmith JA, Randall N, Ross SD. On methods of expressing dissolution rate data. J Pharm Pharmacol. 1978;30:347–9.
CAS
Article
PubMed
Google Scholar
Hanson W. Handbook of dissolution testing. 2nd ed. Eugene Oregon: Aster Publishing Corporation; 1991. p. 35.
Google Scholar
Guidance for Industry: Immediate Release Solid Oral Dosage Forms Scale-up and Postapproval Changes: Chemistry, Manufacturing, and Controls. In Vitro Dissolution Testing and in Vivo Bioequivalence Documentation. Center for Drug Evaluation and Research (CDER), CMC 5. 1995. http://www.fda.gov/downloads/Drugs/…/Guidances/UCM070636.pdf. Accessed Nov 1995.
Gonçalves-Araújo T, Rajabi-Siahboomi AR, Caraballo I. Polymer percolation threshold in HPMC extended release formulation of carbamazepine and verapamil HCl. AAPS PharmSciTech. 2010;11(2):558–62.
Article
PubMed
PubMed Central
Google Scholar
Berens AR, Hopfenberg HB. Diffusion and relaxation in glassy polymer powders: 2. Separation of diffusion and relaxation parameters. Polymer. 1978;19(5):489–96.
CAS
Article
Google Scholar
Dürig T, Fassihi R. Guar-based monolithic matrix systems: effect of ionizable and non-ionizable substances and excipients on gel dynamics and release kinetics. J Control Release. 2002;80(1):45–56.
Article
PubMed
Google Scholar
Peppas NA, Sahlin JJ. A simple equation for the description of solute release. III. Coupling of diffusion and relaxation. Int J Pharm. 1989;57(2):169–72.
CAS
Article
Google Scholar
Pham AT, Lee PI. Probing the mechanisms of drug release from hydroxypropylmethyl cellulose matrices. Pharm Res. 1994;11(10):1379–84.
CAS
Article
PubMed
Google Scholar
Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci. 2001;13(2):123–33.
CAS
Article
PubMed
Google Scholar
USP, General Chapter “ < 711 > Dissolution” USP 34-NF 29. Rockville: The United States Pharmacopeial Convention, 2011. p. 278–284.
USP, General Chapter “ < 724 > Drug release” USP 34-NF 29. Rockville: The United States Pharmacopeial Convention, 2011. p. 285–289.
USP, General Chapter “ < 1088 > In vitro and in vivo evaluation of dosage forms” USP 34-NF 29. Rockville: The United States Pharmacopeial Convention, 2011. p. 612–617.
USP, General Chapter “ < 1225 > Validation of compendial procedures” USP 34-NF 29. Rockville: The United States Pharmacopeial Convention, 2011. p. 778–782.
Guidance for Industry: Waiver of in vivo bioavailability and bioequivalence studies for immediate-release solid oral dosage forms based on a biopharmaceutics classification system. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER). 2015. http://www.fda.gov/downloads/Drugs/…/Guidances/ucm070246.pdf. Accessed May 2015.
Note for guidance on the investigation of bioavailability and bioequivalence. Committee for Proprietary Medicinal Products (CPMP). 2000. http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003519.pdf. Accessed 14 Dec 2000.